Lin L - Search Results

1

Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the l-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade.

Hu Y, Lin L, Chen J, Hao K, Zhang S, Guo X, Guo Z, Tian H, Chen X. Hu Y, et al. Among authors: lin l. ACS Appl Mater Interfaces. 2020 Sep 16;12(37):41127-41137. doi: 10.1021/acsami.0c12734. Epub 2020 Sep 1. ACS Appl Mater Interfaces. 2020. PMID: 32808767

2

Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.

Guan X, Chen J, Hu Y, Lin L, Sun P, Tian H, Chen X. Guan X, et al. Among authors: lin l. Biomaterials. 2018 Jul;171:198-206. doi: 10.1016/j.biomaterials.2018.04.039. Epub 2018 Apr 21. Biomaterials. 2018. PMID: 29698869

3

Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.

Guan X, Lin L, Chen J, Hu Y, Sun P, Tian H, Maruyama A, Chen X. Guan X, et al. Among authors: lin l. J Control Release. 2019 Jan 10;293:104-112. doi: 10.1016/j.jconrel.2018.11.022. Epub 2018 Nov 23. J Control Release. 2019. PMID: 30476528

4

Cyanine-Assisted Exfoliation of Covalent Organic Frameworks in Nanocomposites for Highly Efficient Chemo-Photothermal Tumor Therapy.

Wang K, Zhang Z, Lin L, Hao K, Chen J, Tian H, Chen X. Wang K, et al. Among authors: lin l. ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39503-39512. doi: 10.1021/acsami.9b13544. Epub 2019 Oct 22. ACS Appl Mater Interfaces. 2019. PMID: 31580067

5

A Strategy of Killing Three Birds with One Stone for Cancer Therapy through Regulating the Tumor Microenvironment by H₂O₂-Responsive Gene Delivery System.

Fang H, Chen J, Lin L, Liu F, Tian H, Chen X. Fang H, et al. Among authors: lin l. ACS Appl Mater Interfaces. 2019 Dec 26;11(51):47785-47797. doi: 10.1021/acsami.9b18144. Epub 2019 Dec 11. ACS Appl Mater Interfaces. 2019. PMID: 31773940

6

Helix Self-Assembly Behavior of Amino Acid-Modified Camptothecin Prodrugs and Its Antitumor Effect.

Guo Z, Lin L, Hao K, Wang D, Liu F, Sun P, Yu H, Tang Z, Chen M, Tian H, Chen X. Guo Z, et al. Among authors: lin l. ACS Appl Mater Interfaces. 2020 Feb 12;12(6):7466-7476. doi: 10.1021/acsami.9b21311. Epub 2020 Jan 29. ACS Appl Mater Interfaces. 2020. PMID: 31958004

7

Poly(l-glutamic acid)-Based Zwitterionic Polymer in a Charge Conversional Shielding System for Gene Therapy of Malignant Tumors.

Chen J, Guo Z, Jiao Z, Lin L, Xu C, Tian H, Chen X. Chen J, et al. Among authors: lin l. ACS Appl Mater Interfaces. 2020 Apr 29;12(17):19295-19306. doi: 10.1021/acsami.0c02769. Epub 2020 Apr 14. ACS Appl Mater Interfaces. 2020. PMID: 32239907

8

Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger.

Hu Y, Lin L, Chen J, Maruyama A, Tian H, Chen X. Hu Y, et al. Among authors: lin l. Biomaterials. 2020 Sep;252:120114. doi: 10.1016/j.biomaterials.2020.120114. Epub 2020 May 11. Biomaterials. 2020. PMID: 32422491

9

Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy.

Chen J, Fang H, Hu Y, Wu J, Zhang S, Feng Y, Lin L, Tian H, Chen X. Chen J, et al. Among authors: lin l. Bioact Mater. 2021 Jun 4;7:167-180. doi: 10.1016/j.bioactmat.2021.05.036. eCollection 2022 Jan. Bioact Mater. 2021. PMID: 34466725 Free PMC article.

10

Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo.

Fang H, Guo Z, Chen J, Lin L, Hu Y, Li Y, Tian H, Chen X. Fang H, et al. Among authors: lin l. Nat Commun. 2021 Nov 18;12(1):6742. doi: 10.1038/s41467-021-27078-x. Nat Commun. 2021. PMID: 34795289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,135 results

Search Page

Filters